Ziprasidone Clinical Trials

• Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00257192 - Recruiting
  Schizophrenia
  
• Safety and Tolerability of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00265382 - Recruiting
  Schizophrenia
  
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00265330 - Recruiting
  Bipolar Disorder
  
• Treatment With Ziprasidone for Schizophrenia Patients With OCD
  ClinicalTrials.gov Identifier: NCT00229385 - Recruiting
  Scizophrenia; Obsessive Compulsive Disorder
  
• Treatment of Schizophrenic Patients With Ziprasidone
  ClinicalTrials.gov Identifier: NCT00579670 - Enrolling by invitation
  Schizophrenia
  
• Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
  ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
  Affective Disorders
  
• Pfizer/IVGTT/Ziprasidone/Olanzapine
  ClinicalTrials.gov Identifier: NCT00205725 - Active, not recruiting
  Schizophrenia; Type 2 Diabetes Mellitus
  
• Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial
  ClinicalTrials.gov Identifier: NCT00224315 - Active, not recruiting
  Schizophrenia, Schizoaffective Disorder
  
• Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031
  ClinicalTrials.gov Identifier: NCT00174447 - Active, not recruiting
  Schizophrenia
  
• Extension Study
  ClinicalTrials.gov Identifier: NCT00139737 - Active, not recruiting
  Schizophrenia
  
• Ziprasidone in Children With Autism: A Pilot Study
  ClinicalTrials.gov Identifier: NCT00208559 - Active, not recruiting
  Autism
  
• Ziprasidone and Sertraline in PTSD
  ClinicalTrials.gov Identifier: NCT00248261 - Recruiting
  Post-Traumatic Stress Disorder
  
• Zoom Study: Ziprasidone And Olanzapine's Outcomes In Mania
  ClinicalTrials.gov Identifier: NCT00329108 - Recruiting
  Bipolar Disorder
  
• Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
  ClinicalTrials.gov Identifier: NCT00458211 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Non-Interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders
  ClinicalTrials.gov Identifier: NCT00454883 - Active, not recruiting
  Bipolar Disorder; Psychotic Disorder
  
• Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
  ClinicalTrials.gov Identifier: NCT00225498 - Recruiting
  Schizophrenia
  
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
  ClinicalTrials.gov Identifier: NCT00406315 - Recruiting
  Schizophrenia or Schizoaffective Disorder
  
• 3-Week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
  ClinicalTrials.gov Identifier: NCT00312494 - Recruiting
  Bipolar Disorder
  
• Treatment and Outcome of Early Onset Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
  Bipolar Disorder
  
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00257166 - Completed
  Bipolar Disorder
  
• Energy Homoeostasis Under Treatment with Atypical Antipsychotics
  ClinicalTrials.gov Identifier: NCT00148564 - Recruiting
  Schizophrenia
  
• Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181922 - Active, not recruiting
  Bipolar Disorder; Mania
  
• High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms
  ClinicalTrials.gov Identifier: NCT00403546 - Recruiting
  Schizophrenia
  
• Improving Diabetes Risk Factors in Mexican-American Persons With Schizophrenia by Switching to Ziprasidone
  ClinicalTrials.gov Identifier: NCT00538642 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizioaffective Disorder
  ClinicalTrials.gov Identifier: NCT00137020 - Completed
  Schizophrenia; Psychotic Disorders
  
• Switching Medication to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
  Schizophrenia
  
• Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness
  ClinicalTrials.gov Identifier: NCT00199940 - Recruiting
  Schizophrenia; Affective Disorders; Psychotic; Psychotic Mood Disorder
  
• Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
  ClinicalTrials.gov Identifier: NCT00338949 - Recruiting
  Schizophrenia; Metabolic Syndrome X; Insulin Resistance
  
• Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00280566 - Recruiting
  Bipolar Disorder
  
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
  ClinicalTrials.gov Identifier: NCT00490542 - Recruiting
  Bipolar Disorder; Bipolar Depression; Depression
  
• Open-Label Ziprasidone Study for Psychosis Treatment in Adolescents
  ClinicalTrials.gov Identifier: NCT00421954 - Recruiting
  Schizophreniform Disorder; Schizoaffective Disorder; Psychosis; Depressive Disorder, Major; Bipolar Disorder
  
• Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00395031 - Recruiting
  Schizophrenia; Schizoaffective Disorder
  
• A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression
  ClinicalTrials.gov Identifier: NCT00141271 - Recruiting
  Bipolar Disorder
  
• Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
  ClinicalTrials.gov Identifier: NCT00483548 - Recruiting
  Bipolar Disorder; Depression, Bipolar
  
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00374543 - Recruiting
  Generalized Anxiety Disorder; Bipolar Disorder
  
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
  ClinicalTrials.gov Identifier: NCT00555997 - Not yet recruiting
  Major Depressive Disorder
  
• Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00351000 - Completed
  Schizophrenia
  
• Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)
  ClinicalTrials.gov Identifier: NCT00418171 - Completed
  Schizophrenia
  
• Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle
  ClinicalTrials.gov Identifier: NCT00297960 - Completed
  Healthy Male Volunteers
  
• Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
  ClinicalTrials.gov Identifier: NCT00159770 - Completed
  Schizophrenia; Schizoaffective Disorder; Psychotic Disorders
  
• Mozart Relapse Study
  ClinicalTrials.gov Identifier: NCT00143351 - Completed
  Schizophrenia
  
• Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism
  ClinicalTrials.gov Identifier: NCT00197951 - Completed
  Depression; Anger; Anxiety; Alcoholism
  
• Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
  ClinicalTrials.gov Identifier: NCT00239109 - Completed
  Schizophrenia
  
• IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)
  ClinicalTrials.gov Identifier: NCT00136994 - Completed
  Schizophrenia
  
• CATIE- Schizophrenia Trial
  ClinicalTrials.gov Identifier: NCT00014001 - Completed
  Schizophrenia
  
• Kahn Study
  ClinicalTrials.gov Identifier: NCT00145444 - Completed
  Schizophrenia; Psychotic Disorders
  
• The MIND Study: Modifying the INcidence of Delirium
  ClinicalTrials.gov Identifier: NCT00096863 - Completed
  Delirium; Cognition Disorders
  
• Geodon (Ziprasidone) for Posttraumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00208208 - Completed
  Posttraumatic Stress Disorder; Post-Traumatic Stress Disorder; PTSD